SPTX (Seaport Therapeutics) Total Assets: $249.01 Mil (As of Dec. 2025)


SPTX Seaport Therapeutics Inc SPTX
11 GF Score
Price $21.43
! 1 Warning Sign
View Full Analysis

What is Seaport Therapeutics Total Assets?

Seaport Therapeutics SPTX +10.37% 11 Total Assets is $249.01 Mil as of Dec. 2025. GuruFocus rates SPTX with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Seaport Therapeutics's Total Assets for the quarter that ended in Dec. 2025 was $249.01 Mil.

During the past 12 months, Seaport Therapeutics's average Total Assets Growth Rate was 394.50% per year.

Total Assets is connected with ROA %. Seaport Therapeutics's annualized ROA % for the quarter that ended in Dec. 2025 was -26.52%. Total Assets is also linked to Revenue through Asset Turnover. Seaport Therapeutics's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Seaport Therapeutics  (NAS:SPTX) Total Assets Explanation

Total Assets is connected with ROA %.

Seaport Therapeutics's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Dec. 2025 ))/ count )
=-74.881/( (315.777+249.009)/ 2 )
=-74.881/282.393
=-26.52 %

Note: The Net Income data used here is one times the annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Seaport Therapeutics's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (315.777+249.009)/ 2 )
=0/282.393
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Seaport Therapeutics Total Assets Related Terms

Seaport Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Seaport Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seaport Therapeutics Total Assets Chart

Seaport Therapeutics Annual Data
Trend Dec24 Dec25
Total Assets
315.78 249.01

Seaport Therapeutics Semi-Annual Data
Dec24 Dec25
Total Assets 315.78 249.01
SPTX
11GF Score
Seaport Therapeutics Inc SPTX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seaport Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Seaport Therapeutics's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-92.545+341.554
=249.01

Seaport Therapeutics's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-92.545+341.554
=249.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $249.01 Mil mean?
Seaport Therapeutics (SPTX) has a Total Assets of $249.01 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Seaport Therapeutics and its competitors.
Is Seaport Therapeutics' Total Assets too high?
Seaport Therapeutics' current Total Assets is $249.01 Mil. Overall, Seaport Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Seaport Therapeutics' Total Assets compare to LXRX and DRTS?
Seaport Therapeutics' Total Assets of $249.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Seaport Therapeutics and its competitors. Seaport Therapeutics's current Total Assets is $249.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seaport Therapeutics stock overvalued right now?
Seaport Therapeutics (SPTX) has a current Total Assets of $249.01 Mil. The current Total Assets is $249.01 Mil. Seaport Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Seaport Therapeutics (SPTX), the current Total Assets is $249.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Seaport Therapeutics Business Description

Address 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
11GF Score

Get the complete analysis for SPTX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.43
Price